Prevalências e desigualdades no acesso aos medicamentos por usuários do Sistema Único de Saúde no Brasil em 2013 e 2019
Abstract
The study aimed to analyze and compare the prevalence of access to medicines and associated factors among users of the Brazilian Unified National Health System (SUS). The authors analyzed data from the 2013 and 2019 editions of the Brazilian National Health Survey, a nationwide health study, representative of the Brazilian population. The outcomes were: (1) obtaining from the SUS all the medicines prescribed during care received in the SUS itself in the two weeks prior to the interview (2) and obtaining all the medicines, regardless of the source. Demographic and socioeconomic characteristics were included as independent variables. In 2019, 29.7% of the interviewees obtained all the prescribed medicines from the SUS, 81.8% obtained all the medicines in general (considering all sources), and 56.4% paid some amount for the medicines. The proportion who did obtain any medicine from the SUS and that made some out-of-pocket payment increased from 2013 to 2019. The likelihood of obtaining all the medicines in the SUS was higher among the poorest, and that of obtaining the medicines regardless of source was higher among the wealthiest. Approximately two out of three persons that were unable to access all the medicines reported difficulties obtaining them in services funded by the public sector. There was an increase in out-of-pocket expenditure on medicines in Brazil and a reduction in access through the SUS, among users of the system.
Related
- Pandemia, Sistema Único de Saúde (SUS) e Saúde Coletiva: com-posições e aberturas para mundos outros
- Estado de Coherencia Neurofisiológica (ECN) como Variable Experimental en la Interacción Cerebro–Sistema Inmune: Un Marco para la Psiconeuroinmunología Individualizada
- SUSPEITA DE ANOMALIA DE PELGER-HUËT MIMETIZANDO DESVIO À ESQUERDA MASSIVO EM PACIENTE COM INFECÇÃO DO SISTEMA NERVOSO CENTRAL E HEPATOPATIA: RELATO DE CASO
- ATLL FORMA LINFOMATOSA COM HIPERCALCEMIA GRAVE E ACOMETIMENTO DE SISTEMA NERVOSO CENTRAL: RELATO DE CASO DE EVOLUÇÃO RAPIDAMENTE PROGRESSIVA
BibTeX
@article{boing2026prevalências,
title = {{Prevalências e desigualdades no acesso aos medicamentos por usuários do Sistema Único de Saúde no Brasil em 2013 e 2019}},
author = {Alexandra Crispim Boing and Fabiola Bof De Andrade and Andréa Dâmaso Bertoldi and Karen Glazer de Anselmo Peres and Adriano Massuda and Antonio Fernando Boing},
journal = {Cadernos de Saúde Pública},
year = {2026},
month = oct,
doi = {10.1590/0102-311xpt114721},
url = {https://hal.science/hal-05791958v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Prevalências e desigualdades no acesso aos medicamentos por usuários do Sistema Único de Saúde no Brasil em 2013 e 2019
AU - Alexandra Crispim Boing
AU - Fabiola Bof De Andrade
AU - Andréa Dâmaso Bertoldi
AU - Karen Glazer de Anselmo Peres
AU - Adriano Massuda
AU - Antonio Fernando Boing
PY - 2026
DA - 2026/10/11
JO - Cadernos de Saúde Pública
DO - 10.1590/0102-311xpt114721
UR - https://hal.science/hal-05791958v1
AB - The study aimed to analyze and compare the prevalence of access to medicines and associated factors among users of the Brazilian Unified National Health System (SUS). The authors analyzed data from the 2013 and 2019 editions of the Brazilian National Health Survey, a nationwide health study, representative of the Brazilian population. The outcomes were: (1) obtaining from the SUS all the medicines prescribed during care received in the SUS itself in the two weeks prior to the interview (2) and obtaining all the medicines, regardless of the source. Demographic and socioeconomic characteristics were included as independent variables. In 2019, 29.7% of the interviewees obtained all the prescribed medicines from the SUS, 81.8% obtained all the medicines in general (considering all sources), and 56.4% paid some amount for the medicines. The proportion who did obtain any medicine from the SUS and that made some out-of-pocket payment increased from 2013 to 2019. The likelihood of obtaining all the medicines in the SUS was higher among the poorest, and that of obtaining the medicines regardless of source was higher among the wealthiest. Approximately two out of three persons that were unable to access all the medicines reported difficulties obtaining them in services funded by the public sector. There was an increase in out-of-pocket expenditure on medicines in Brazil and a reduction in access through the SUS, among users of the system.
SN - 0102-311X
SN - 1678-4464
ER -